Castle Biosciences Inc share price logo

Castle Biosciences Inc Share Price

NASDAQ: CSTL

Small Cap

$21.82

+0.07

(+0.32%)

as on

Castle Biosciences Inc Stock Performance

as on September 18, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $21.68
    $22.57
    downward going graph

    0.64%

    Downside

    3.44%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $14.59
    $35.84
    downward going graph

    33.13%

    Downside

    64.25%

    Upside

    downward going graph

Castle Biosciences Inc share price movements today

Previous Close
$21.75
Open
$21.79
Volume
311.3K
Day's Low - High
$21.68 - $22.57
52 Week Low - High
$14.59 - $35.84

Castle Biosciences Inc Historical Returns

1 Month Return
+ 6.13 %
3 Month Return
+ 15.39 %
1 Year Return
-28.13 %
3 Year Return
-19.63 %
5 Year Return
-57.25 %

Castle Biosciences Inc Stock Fundamentals & Key Indicators

Check Castle Biosciences Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$633.0M

EPS (TTM)

-1.5557

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.52%

PE Ratio (TTM)

-265.38

Industry PE ratio

-3.9415151515151514

P/B Ratio

0

PEG Ratio

0

EBITDA

19.4M

Revenue (TTM)

346.3M

Profit Margin

-2.73%

Return On Equity TTM

4739800.00%

Castle Biosciences Inc Stock Valuation

Track how Castle Biosciences Inc P/E has moved over time to understand its valuation trends.

Castle Biosciences Inc in the last 5 years

  • Overview

  • Trends

Lowest (49.12x)

December 31, 2024

Today (-265.38x)

September 18, 2025

Industry (-3.94x)

September 18, 2025

Highest (127.26x)

September 30, 2024

LowHigh

Today’s Price to Earnings Ratio: -265.38x

Castle Biosciences Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Castle Biosciences Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$633.0M-57.25%-265.38-2.73%
BUY$51.3B80.65%53.1824.41%
BUY$35.9B27.51%29.5417.97%
BUY$31.7B18.82%27.17.88%
BUY$178.5B12.05%27.3215.24%

Stock Returns calculator for Castle Biosciences Inc Stock including INR - Dollar returns

The Castle Biosciences Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Castle Biosciences Inc investment value today

Current value as on today

₹76,469

Returns

₹23,531

(-23.53%)

Returns from Castle Biosciences Inc Stock

₹28,129 (-28.13%)

Dollar Returns*

₹4,598 (+4.6%)

Analyst Recommendation on Castle Biosciences Inc Stock

Based on 15 analysts

BUY

93.33%

Buy

6.67%

Hold

0.00%

Sell

Based on 15 analysts, 93.33% of analysts recommend a 'BUY' rating for Castle Biosciences Inc. Average target price of $35.62

Castle Biosciences Inc Share Price Target

Get share price movements and forecasts by analysts on Castle Biosciences Inc.

What analysts predicted

38.74%UPSIDE

Target Price

$35.62

Current Price

$21.82

Analyzed by

15 Analysts

Target

$35.62

Castle Biosciences Inc target price $35.62, a slight upside of 38.74% compared to current price of $21.82. According to 15 analysts rating.

Castle Biosciences Inc Stock's Interest Amongst Investors

Search interest for Castle Biosciences Inc Stock has decreased by -57% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-57% versus previous 30 day period

Castle Biosciences Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
42
50
61
66
72
87
85
86
87
86
Gross Profit
31
39
50
51
56
69
70
70
71
66
Operating Income
-31
-21
-9
-5
-5
5
5
4
-27
-4
EBITDA
-26
-15
-3
0
0
11
12
13
3
-4
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
2
3
3
3
3
3
3
5
29
3
Income Before Tax
-29
-18
-6
-2
-2
7
8
7
-26
0
Income Tax Expense
0
0
0
0
0
-1
6
-1
0
-4
Net Income
-29
-18
-6
-2
-2
8
2
9
-25
4
Net Profit Margin
-69.47%
-37.45%
-11.23%
-3.90%
-3.47%
10.25%
2.65%
11.11%
-29.38%
5.25%

Castle Biosciences Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
13
22
51
62
94
137
219
332
Gross Profit
8
17
44
52
78
105
174
271
Operating Income
-10
-3
4
-6
-40
-91
-67
8
EBITDA
-10
-3
7
-7
-36
-58
-45
38
Interest Expense
1
2
4
2
0
0
0
0
Depreciation
0
0
0
0
3
10
11
15
Income Before Tax
-12
-6
5
-10
-40
-68
-57
21
Income Tax Expense
0
0
0
0
-8
-1
0
3
Net Income
-12
-6
5
-10
-31
-67
-57
18
Net Profit Margin
-89.93%
-27.94%
10.17%
-16.42%
-33.26%
-48.99%
-26.15%
5.49%

Castle Biosciences Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-18
-6
-2
-2
8
2
9
-25
4
Operating Cash Flow
-3
5
24
-6
23
23
24
-6
20
Investing Cash Flow
-15
-9
-7
-19
-21
-14
5
-22
-28
Financing Cash Flow
0
0
-3
10
0
0
-5
-1
0
Change in Cash
-18
-4
7
-15
2
9
24
-30
-7

Castle Biosciences Inc Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-6
5
-10
-31
-67
-57
18
Operating Cash Flow
-12
7
9
-18
-41
-5
64
Investing Cash Flow
0
0
-4
-66
-166
-16
-50
Financing Cash Flow
15
88
305
5
1
-2
6
Change in Cash
3
94
311
-80
-206
-24
20

Global Institutional Holdings in Castle Biosciences Inc

Funds
Holdings
BlackRock Inc
10.29%
Vanguard Group Inc
7.06%
Principal Financial Group Inc
5.06%
Portolan Capital Management, LLC
4.36%
Dimensional Fund Advisors, Inc.
4.14%

Insights on Castle Biosciences Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -25.84M → 4.52M (in $), with an average increase of 671.5% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Idexx Laboratories, Inc. has given 87.1% return, outperforming this stock by 106.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Idexx Laboratories, Inc. has given 25.3% return, outperforming this stock by 53.4%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 87.98M → 86.18M (in $), with an average decrease of 2.1% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, CSTL stock has moved down by -4.1%

About Castle Biosciences Inc

castle biosciences, inc. specializes in diagnostic tests for cancers. founded in 2008, the company goal has been to help advance the care for cancers through objective testing. our team works with outstanding members of the oncology community throughout the discovery, development and utilization of these tests. currently, castle biosciences has tests to help doctors treat cutaneous melanoma, uveal melanoma, esophageal adenocarcinoma, mesothelioma and glioma. we have active research programs in rectal cancer and soft tissue sarcoma, and anticipate tests for these and other under-served cancers to be available in the near future please visit us at www.castlebiosciences.com for more information on our company and products.
OrganisationCastle Biosciences Inc
Headquarters505 S. Friendswood Drive, Friendswood, TX, United States, 77546
IndustryHealth Technology
CEOMr. Derek J. Maetzold
E-voting on sharesClick here to vote

Key Management of Castle Biosciences Inc

Name

Title

Dr. Jay Braxton Pharm.D.

VP of Marketing & Brand Manager of Uveal Melanoma (UM)

Ms. Keli Greenberg

Vice President of Human Resources

Mr. Derek J. Maetzold

Founder, CEO, President & Director

Mr. Frank Stokes

CFO & Treasurer

Mr. Tobin W. Juvenal

Chief Commercial Officer

Dr. Matthew Goldberg M.D.

Senior Vice President of Medical

Ms. Kristen M. Oelschlager R.N.

Chief Operating Officer

Ms. Camilla Zuckero

Vice President of Investor Relations & Corporate Affairs

Mr. Kevin Doman

Vice President of Sales

FAQs

What is Castle Biosciences Inc share price today?

Castle Biosciences Inc share price today is $21.82 as on at the close of the market. Castle Biosciences Inc share today touched a day high of $22.57 and a low of $21.68.

What is the 52 week high and 52 week low for Castle Biosciences Inc share?

Castle Biosciences Inc share touched a 52 week high of $35.84 on and a 52 week low of $14.59 on . Castle Biosciences Inc stock price today i.e. is closed at $21.82,which is 39.12% down from its 52 week high and 49.55% up from its 52 week low.

What is Castle Biosciences Inc's market capitalisation today?

Castle Biosciences Inc market capitalisation is $0.00T as on .

How to invest in Castle Biosciences Inc Stock (CSTL) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Castle Biosciences Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Castle Biosciences Inc Shares that will get you 0.0687 shares as per Castle Biosciences Inc share price of $21.82 per share as on September 18, 2025 at 1:29 am IST.

What is the minimum amount required to buy Castle Biosciences Inc Stock (CSTL) from India?

Indian investors can start investing in Castle Biosciences Inc (CSTL) shares with as little as ₹87.816 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Castle Biosciences Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Castle Biosciences Inc share’s latest price of $21.82 as on September 18, 2025 at 1:29 am IST, you will get 0.4583 shares of Castle Biosciences Inc. Learn more about fractional shares .

What are the returns that Castle Biosciences Inc has given to Indian investors in the last 5 years?

Castle Biosciences Inc stock has given -57.25% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?